PROCESSA PHARMACEUTICALS INC
(NASDAQ: PCSA)
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Hanover, MD.
2.170
-0.090
(-3.98%)
Range
2.150 - 2.300
(6.98%)
Open
2.300
Previous Close
2.260
Bid Price
0.636
Bid Volume
10
Ask Price
0.670
Ask Volume
29
Volume
91,353
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis